Renal prostaglandins and hypertension.
J C
JC
McGiff
M
M
Schwartzmann
N R
NR
Ferreri
D015121:6-Ketoprostaglandin F1 alpha / Q000494:pharmacology; D000818:Animals; D007611:Aprotinin / Q000494:pharmacology; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D003900:Desoxycorticosterone / Q000494:pharmacology; D015232:Dinoprostone; D011464:Epoprostenol / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D007610:Kallikreins / Q000378:metabolism; D007668:Kidney / Q000502:physiology*; D007705:Kinins / Q000378:metabolism; D008954:Models, Biological; D009318:Natriuresis / Q000187:drug effects; D009399:Nephrons / Q000378:metabolism; D011453:Prostaglandins / Q000502:physiology*; D011458:Prostaglandins E / Q000502:physiology; D012083:Renin / Q000097:blood; D014554:Urination
D001095:Arachidonic Acids; D007705:Kinins; D011453:Prostaglandins; D011458:Prostaglandins E; D016718:Arachidonic Acid; D003900:Desoxycorticosterone; D015121:6-Ketoprostaglandin F1 alpha; D007611:Aprotinin; D011464:Epoprostenol; D007610:Kallikreins; D012083:Renin; D015232:Dinoprostone